United States, bridging the gap between university and industry in drug discovery
The Johns Hopkins School of Medicine’s Brain Science Institute will bring together top figures from US industry and academia in an open event on 18 October.
The business of drug discovery is changing. Over the last several years a new model has emerged bridging academic translational strengths with the pharmaceutical and biotechnology industries. What are the opportunities, challenges and risks to be addressed to forge these alliances? What are best practices? What could this new future look like?
The Johns Hopkins School of Medicine’s Brain Science Institute (BSi) is holding an international conference entitled Drug Discovery in Academia Conference: The New Paradigm for Drug Discovery in Baltimore (Maryland, United States) on 18 October to discuss these questions.
The top-notch agenda is headed by Dr. Steven M. Paul, director of the Helen and Robert Appel Alzheimer’s Disease Research Institute and professor of Neurosciences, Psychiatry and Pharmacology at Weill Cornell Medical College, who will give the keynote lecture: Academic Translational Centers, A New Paradigm for Early Stage Drug Discovery.
The program of lectures will include participation from directors at multinational companies like Merck, Pfizer, AstraZeneca, GlaxoSmithKline, among others; at world-renowned research centers and universities like the University of California, the Canadian Centre for Drug Research and Development, Harvard University, Johns Hopkins University, the University of North Carolina and Vanderbilt University. Furthermore, centers for drug-development funding like the National Institutes of Health, the Maryland Biotechnology Center and New Enterprise Associates will also be in attendance.
The day before the event (17 October 2011), the Johns Hopkins BSi and the Johns Hopkins Technology Transfer Center will facilitate partnering meetings between industry and various participants from academia.
Biocat and the Johns Hopkins Technology Transfer Center signed a collaboration agreement in 2010 to drive mutual collaboration on research, technology transfer and business entrepreneurship in the field of life sciences.
Date: 18 October 2011
Time: 7:00 am – 6:30 pm
Lloc: Baltimore Convention Center • One West Pratt Street • Baltimore (Maryland, USA)